Gesynta Pharma


Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.

Headquarters

Stockholm, Sweden

Employees

1-10

Links


Org chart

Patric Stenberg
Co-founder And CEO
Collapse
Michaela Gertz
Chief Financial Officer
Göran Tornling
Chief Medical Officer
Charlotte Edenius
VP, Clinical R&D
Gunilla Ekström
VP, Project Management
Sven Sievers
Commercial Manager

Board & advisors



Offices